Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer
Status:
Unknown status
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare neo-adjuvant therapy of cytotoxic chemotherapy versus
GnRHa with tamoxifen , of response rate(RR) in patients of hormone responsive and HER2
negative, lymph node positive, primary breast cancer in premenopausal women.